Phenotype measures set:   Wiltshire4   Bcells_Dox

ID, description, units MPD:52421   Bcells_Dox   B cells, percent viability   [%]
doxorubicin study
Measures • dose [µM]:    • control    • 0.046    • 0.137    • 1.235    • 11.1    • 100
Data set, strains Wiltshire4   inbred w/CC7   35 strains     sex: m     age: 10wks
Procedure immune cell quantification
Comparisoncontrol group vs. multiple treatment / dosage groups
Ontology mappings

  SIDE-BY-SIDE STRAIN CURVES
Values
Graph Type
Dimensions Width:  ×  Height: px
Plot Options


  OVERLAPPING STRAIN CURVES
Data
Dimensions px
Toggle Series   
Plot Options

Wiltshire4 - B cells, percent viability





  ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary     

Factor DF Sum of squares Mean sum of squares F value p-value (Pr>F)
dose 5 843915.1531 168783.0306 682.3585 < 0.0001
strain 33 118041.3705 3577.0112 14.4612 < 0.0001
dose:strain 165 114244.8831 692.3932 2.7992 < 0.0001
Residuals 593 146679.9782 247.3524

Q-Q normality assessment based on residuals

  


  INDIVIDUAL MEASURES
ProjectIDDrug or
challenge
Description and varname PanelStrains
tested
SexAge
Wiltshire4 52421 immune cell quantification doxorubicin B cells, percent viability   [%]   control   Bcells_Dox_ctrl inbred w/CC7 35 m 10wks
Wiltshire4 52422 immune cell quantification doxorubicin B cells, percent viability   [%]   dose: 0.046 µM   Bcells_Dox_A inbred w/CC7 35 m 10wks
Wiltshire4 52423 immune cell quantification doxorubicin B cells, percent viability   [%]   dose: 0.137 µM   Bcells_Dox_B inbred w/CC7 35 m 10wks
Wiltshire4 52424 immune cell quantification doxorubicin B cells, percent viability   [%]   dose: 1.235 µM   Bcells_Dox_C inbred w/CC7 35 m 10wks
Wiltshire4 52425 immune cell quantification doxorubicin B cells, percent viability   [%]   dose: 11.1 µM   Bcells_Dox_D inbred w/CC7 35 m 10wks
Wiltshire4 52426 immune cell quantification doxorubicin B cells, percent viability   [%]   dose: 100 µM   Bcells_Dox_E inbred w/CC7 35 m 10wks